![](https://www.microbiometimes.com/wp-content/uploads/2021/10/shutterstock_1853534521-2-326x245.jpg)
Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research
Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that it has entered into a licensing agreement with The Walter Reed Army Institute of Research (WRAIR) […]